← Back to Search

iKinnect2.0 App for Suicide Risk in Youth

N/A

Recruiting

Led By Cindy Schaeffer, PhD

Research Sponsored by Evidence-Based Practice Institute, Seattle, WA

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

PARENT/GUARDIAN: 18 years or older

YOUTH: Age 15-21 years

Timeline

Screening 3 weeks

Treatment Varies

Follow Up baseline (time1), 1-4 weeks (time 2), 5-8 weeks (time 3), and 9-16 weeks (time 4)

Summary

This trial will test a new app, iKinnect2.0, for suicide prevention in 120 young adults aged 15-21 who have been involved in the juvenile justice system, compared to an existing app, Life360, plus an electronic suicide resources brochure.

Who is the study for?

This trial is for English-speaking youth aged 15-21 at high risk of suicide, with a history of self-harm or attempts, who use a smartphone with data and live with their primary caregiver. Caregivers must also participate, be fluent in English, and have a smartphone. Youth should be involved in juvenile justice services.

What is being tested?

The study compares iKinnect2.0, an app designed to help prevent suicide among young people involved in the juvenile justice system, against Life360 (a control app) plus electronic resources on suicide prevention over a period of 16 weeks.

What are the potential side effects?

There are no direct physical side effects mentioned for participating in this trial as it involves the use of mobile applications; however, discussing sensitive topics like suicidal behavior may cause emotional discomfort.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am a parent or guardian aged 18 or older.

Select...

I am between 15 and 21 years old.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ baseline (time1), 1-4 weeks (time 2), 5-8 weeks (time 3), and 9-16 weeks (time 4)

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~baseline (time1), 1-4 weeks (time 2), 5-8 weeks (time 3), and 9-16 weeks (time 4)

This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline (time1), 1-4 weeks (time 2), 5-8 weeks (time 3), and 9-16 weeks (time 4) for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Change in Achenbach (Child/Adult) Behavior Checklist

Change in Center for Epidemiological Studies-Depression Scale (CES-D)

Change in Loeber Parenting Scale

+6 more

Trial Design

2Treatment groups

Experimental Treatment

Placebo Group

Group I: iKinnect2.0Experimental Treatment1 Intervention

Parent-Youth dyads assigned to the iKinnect2.0 condition will be given access to the iKinnect2.0 app that has been developed for this study. Parent and youth will be asked to download the app to their phone during the baseline assessment process and asked to use it as often as they would like throughout the duration of the 16 week trial. The app is designed to be used several times throughout each day.

Group II: Attention-Control Placebo App & Supporting MaterialsPlacebo Group1 Intervention

Parent-Youth dyads assigned to the control condition will be asked to download the free Life360 app to their phone during the baseline assessment process and will also be given access to an online suicide resources brochure. Participants will be asked to use the control-condition app and associated materials as often as they would like throughout the duration of the 16 week trial.

0 / 2Eligibility criteria met